Avadel Pharmaceuticals plc · 2 days ago
Field Reimbursement Manager- Central- Chicago
Maximize your interview chances
BiotechnologyInformation Technology
Insider Connection @Avadel Pharmaceuticals plc
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Be a significant player in the development of Avadel’s Market Access Field Reimbursement Strategy across all assets and functions to ensure an integrated approach to broader HCP offices that delivers optimal access for patients to the portfolio, including ensuring an efficient cross-functional communication and feedback process.
Provide critical engagement with HCP office staff educating them on RYZUP enrollment process and titration process so offices understand process when script is written.
It is vital that Field Reimbursement teams develop and maintain strong relationships with each HCP office.
Work together as one Avadel team in owning the relationship development of HCP offices with their respective Territory Business Manager.
Develop service materials to support educational efforts while in the field these are to include: Reimbursement, Prior Authorizations, Letters of Medical Necessity, Appeals, Welcome Kits, Compliance and Persistency, Data integration SP network, Pull-through strategies, Payer Policy, RYZUP process.
Attend Quarterly Business Reviews.
Implementation of Programs, Dinner, Lunch, etc. all educational in nature.
Work Collaboratively across all internal Avadel teams with focus on Patient Support and Channel.
Partner with Finance, Supply Chain, and Manufacturing teams in demand forecasting and pharmacy/wholesaler fulfillment throughout pre-launch and post-launch phases of product to ensure successful implementation of the trade/distribution strategy.
Support and communicate Market Access strategies in partnership with the Payer Marketing team, Head of Contracting & Pricing Strategy, HEOR, Medical Affairs, and other cross-functional and senior corporate leadership, as appropriate.
Be the 'Go To' brand leader in the field for HCP offices to call on when questions arise.
Educate HCP offices regarding REM’s protocol and certification process to ensure offices can prescribe product.
Work collaboratively with all contracted partners.
Provide strong analytical work to improve process and performance, identify key metrics to track performance at a National and regional level.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree required; advanced degree preferred
5+ years’ experience within the Pharma/biotech industry with that focused in either a sales or reimbursement related role
Previous experience working in Reimbursement
Ability to own build critical relationships with office staff
Proven experience with success in pull-through strategies
Experience in development of Field Access educational materials
Previous launch experience directly with field access teams required
Strong analytical expertise with ability to measure metrics and bring insights to data that will make a meaningful impact to patients
Strong knowledge of Patient Services programs such as Copay, Quick Start/Bridge, LMN/Appeals
Certain customers and/or Health Care Professionals may have credentialing requirements that apply to field roles to gain access to perform the essential functions of the position. In these cases, credentialing requirements must be met (which may include vaccinations such as influenza and COVID-19).
Preferred
Experience in the Rare Orphan Disease markets highly preferred
Benefits
Medical
Dental
Vision
Life Insurance
401K
ESPP
Generous vacation, holiday, and personal time off
Company
Avadel Pharmaceuticals plc
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives.
Funding
Current Stage
Public CompanyTotal Funding
$190MKey Investors
Vivo Capital
2023-03-29Post Ipo Equity· $125M
2021-01-01Post Ipo Equity· Undisclosed
2020-02-21Post Ipo Equity· $65M
Recent News
GlobeNewswire News Room
2024-11-12
Company data provided by crunchbase